Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SRT002
MIFTS: 38

Sertoli Cell Tumor

Categories: Cancer diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Sertoli Cell Tumor

About this section

MalaCards integrated aliases for Sertoli Cell Tumor:

Name: Sertoli Cell Tumor 12 54 43 15 71
Tubular Androblastoma 12

Classifications:

MalaCards categories:
Global: Cancer diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:3577
MeSH 43 D012707
NCIt 49 C39976
SNOMED-CT 67 128857001
UMLS 71 C0036769
Sources

Summaries for Sertoli Cell Tumor

About this section
Disease Ontology : 12 A sex cord-gonadal stromal tumor characterized by excessive proliferation of Sertoli cells.

MalaCards based summary : Sertoli Cell Tumor, also known as tubular androblastoma, is related to peutz-jeghers syndrome and gynecomastia. An important gene associated with Sertoli Cell Tumor is CALB2 (Calbindin 2), and among its related pathways/superpathways are Cytoskeletal Signaling and Cytoskeleton remodeling Neurofilaments. The drugs Ipilimumab and nivolumab have been mentioned in the context of this disorder. Affiliated tissues include testis, ovary and testes, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Sources

Related Diseases for Sertoli Cell Tumor

About this section

Diseases related to Sertoli Cell Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 534)
# Related Disease Score Top Affiliating Genes
1 peutz-jeghers syndrome 31.0 PRKAR1A INHA CYP19A1
2 gynecomastia 30.5 PGR INHA CYP19A1 AR
3 androgen insensitivity syndrome 30.5 NR5A1 MUC1 AR
4 carcinoid tumors, intestinal 30.3 SYP ENO2
5 adenoma 30.3 SYP PRKAR1A MUC1 KRT7
6 renal adenoma 30.2 WT1 KRT7
7 spindle cell sarcoma 30.1 VIM MUC1 KRT7
8 ovarian germ cell teratoma 29.9 SYP KRT7 CALB2 AFP
9 gonadoblastoma 29.9 WT1 NR5A1 ALPP
10 complete androgen insensitivity syndrome 29.9 MUC1 CYP19A1 AR
11 seminoma 29.8 INHA ENO2 ALPP AFP
12 germinoma 29.8 INHA ALPP AFP
13 leydig cell tumor 29.8 SYP NR5A1 INHA CYP19A1 CALB2 AFP
14 testicular cancer 29.7 AR ALPP AFP
15 primary pigmented nodular adrenocortical disease 29.6 SYP PRKAR1A PGR CYP19A1
16 pseudohermaphroditism 29.6 WT1 NR5A1 CYP19A1 AR
17 large cell neuroendocrine carcinoma 29.5 SYP KRT7 ENO2 CALB2
18 cryptorchidism, unilateral or bilateral 29.5 WT1 NR5A1 CYP19A1 AR AFP
19 neuroendocrine carcinoma 29.4 SYP MUC1 KRT7 ENO2
20 testicular germ cell tumor 29.4 AR ALPP AFP
21 46,xy sex reversal 29.3 WT1 NR5A1 CYP19A1 AR
22 carcinosarcoma 29.3 WT1 VIM PGR MUC1 KRT7 CALB2
23 teratoma 29.2 VIM SYP KRT7 ENO2 CALB2 AFP
24 adrenal cortical adenoma 29.2 SYP PRKAR1A NR5A1 INHA ENO2
25 disorders of sexual development 29.1 WT1 NR5A1 CYP19A1 AR AFP
26 infertility 29.0 PGR NR5A1 INHA CYP19A1 AR
27 sertoli-leydig cell tumor 28.5 WT1 SYP PGR MUC1 KRT7 INHA
28 renal cell carcinoma, nonpapillary 28.3 WT1 VIM MUC1 KRT8 KRT7 ENO2
29 endometrial cancer 28.3 WT1 PGR MUC1 KRT7 INHA CYP19A1
30 dysgerminoma 27.9 WT1 MUC1 KRT7 INHA ENO2 ALPP
31 wilms tumor 1 27.8 WT1 SYP PGR NR5A1 KRT7 ENO2
32 sex cord-gonadal stromal tumor 27.2 WT1 VIM PRKAR1A PGR NR5A1 MUC1
33 carney complex, type 1 11.6
34 infant gynecomastia 10.6
35 gynandroblastoma 10.6 VIM CALB2
36 fallopian tube carcinosarcoma 10.5 WT1 CALB2
37 dermoid cyst of ovary 10.5 CALB2 AFP
38 testicular gonadoblastoma 10.5 WT1 VIM
39 liver fibroma 10.5 VIM CALB2
40 adrenogenital syndrome 10.5 SYP INHA
41 glomangiomyoma 10.5 VIM SYP
42 lymphangiomatosis 10.5 VIM PGR
43 peritoneal benign neoplasm 10.5 PGR CALB2
44 infected hydrocele 10.5 CALB2 AFP
45 thymus sarcomatoid carcinoma 10.5 SYP AFP
46 cervical clear cell adenocarcinoma 10.5 PGR AFP
47 cervical serous adenocarcinoma 10.5 WT1 PGR
48 esophageal adenoid cystic carcinoma 10.5 VIM SYP
49 angiocentric glioma 10.5 VIM SYP
50 rare tumor 10.5

Graphical network of the top 20 diseases related to Sertoli Cell Tumor:



Diseases related to Sertoli Cell Tumor
Sources

Symptoms & Phenotypes for Sertoli Cell Tumor

About this section

GenomeRNAi Phenotypes related to Sertoli Cell Tumor according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-114 9.28 AFP
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-120 9.28 AFP
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-29 9.28 AFP
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-6 9.28 KRT8
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-63 9.28 AFP
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-65 9.28 AFP
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-71 9.28 KRT7 KRT8
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-75 9.28 AFP

MGI Mouse Phenotypes related to Sertoli Cell Tumor:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.13 AFP AR CALB2 CYP19A1 ENO2 NR5A1
2 cardiovascular system MP:0005385 10.06 AR CYP19A1 INHA KRT8 NR5A1 PGR
3 homeostasis/metabolism MP:0005376 10.06 AFP AR CYP19A1 INHA KRT7 KRT8
4 endocrine/exocrine gland MP:0005379 9.97 AFP AR CYP19A1 INHA NR5A1 PGR
5 liver/biliary system MP:0005370 9.8 AFP AR CYP19A1 INHA KRT8 PRKAR1A
6 neoplasm MP:0002006 9.63 AFP AR INHA PGR PRKAR1A WT1
7 normal MP:0002873 9.61 AR CALB2 CYP19A1 INHA NR5A1 PGR
8 reproductive system MP:0005389 9.32 AFP AR CYP19A1 INHA KRT8 NR5A1
Sources

Drugs & Therapeutics for Sertoli Cell Tumor

About this section

Drugs for Sertoli Cell Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ipilimumab Approved Phase 2 477202-00-9
2
nivolumab Approved Phase 2 946414-94-4
3 Immunoglobulins Phase 2
4 Antibodies Phase 2
5 Antibodies, Monoclonal Phase 2
6 Antineoplastic Agents, Immunological Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) Recruiting NCT03866382 Phase 2 Cabozantinib;Cabozantinib S-malate

Search NIH Clinical Center for Sertoli Cell Tumor

Cochrane evidence based reviews: sertoli cell tumor

Sources

Genetic Tests for Sertoli Cell Tumor

About this section
Sources

Anatomical Context for Sertoli Cell Tumor

About this section

MalaCards organs/tissues related to Sertoli Cell Tumor:

40
Testis, Ovary, Testes, Bone, Prostate, Bone Marrow, Lung
Sources

Publications for Sertoli Cell Tumor

About this section

Articles related to Sertoli Cell Tumor:

(show top 50) (show all 374)
# Title Authors PMID Year
1
Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. 61 54
19033865 2009
2
Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. 54 61
17721194 2007
3
Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. 61 54
15644771 2005
4
Sertoli cell tumor of the testis (not otherwise specified) with the expression of neuroendocrine markers and without the expression of inhibin-alpha. 54 61
15363041 2004
5
A(870)E mutation of the androgen receptor gene in a patient with complete androgen insensitivity syndrome and Sertoli cell tumor. 61 54
9332480 1997
6
Sertoli Cell Tumor of Testes in a Child with Peutz-Jeghers syndrome. 61 54
18417782 1997
7
Be cautious of "complex hydrocele" on ultrasound in young men. 61
32255327 2020
8
Sertoli Cell Tumor With Ossification and Adipose Tissue Differentiation. 61
31311370 2020
9
An Unusual Presentation of Carney Complex 61
31117334 2020
10
Large Cell Calcifying Sertoli Cell Tumor with Macrocalcification in a Partially Resected Testis. 61
32257489 2020
11
Sertoli Cell Tumor (SCT) in a Captive Black Bear (Ursus americanus). 61
31561583 2019
12
Phenotype evolution and health issues of adults with Beckwith-Wiedemann syndrome. 61
31339634 2019
13
Somatic PRKAR1A Gene Mutation in a Nonsyndromic Metastatic Large Cell Calcifying Sertoli Cell Tumor. 61
31286102 2019
14
Recently Described and Clinically Important Entities in Testis Tumors: A Selective Review of Changes Incorporated Into the 2016 Classification of the World Health Organization. 61
29949388 2019
15
Persistent Mullerian duct Syndrome in a Brazilian miniature schnauzer dog. 61
31241703 2019
16
Case Report of Misleading Features of a Rare Sertoli Cell Testicular Tumor. 61
31137577 2019
17
[Organ-sparing partial orchietectomy for testicular adenomatoid tumor]. 61
30996385 2019
18
INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell Tumors. 61
29084059 2019
19
Metastatic testicular Sertoli cell tumor in a free-ranging cryptorchid adult spotted seal Phoca largha in North Slope, Alaska, USA. 61
30997879 2019
20
Ovarian Sex Cord-stromal Tumors With Melanin Pigment: Report of a Previously Undescribed Phenomenon. 61
29140884 2019
21
Sonographic diagnosis of large-cell calcifying Sertoli cell tumor. 61
31355590 2019
22
Malignant Sertoli cell tumor of the testis masquerading as seminoma with bone metastasis. 61
30303161 2018
23
Prepubertal Malignant Large Cell Calcifying Sertoli Cell Tumor of the Testis. 61
29626571 2018
24
[Clinicopathologic and molecular characterizations of Sertoli cell tumor, not otherwise specified of the testis]. 61
29996314 2018
25
Solitary Fibrous Tumors in Pediatric Patients: A Rare and Potentially Overdiagnosed Neoplasm, Confirmed by STAT6 Immunohistochemistry. 61
29228868 2018
26
Testis-sparing surgery of unilateral testicular large-cell calcifying Sertoli cell tumor: a sporadic case. 61
29799406 2018
27
Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review. 61
28700436 2018
28
Pazopanib treatment of a platinum-resistant recurrence of a high-grade Sertoli cell tumor and assessment of the treatment response by FDG-PET/CT: A case report. 61
29915800 2018
29
Estrogen-induced myelotoxicity in a 4-year-old golden retriever dog due to a Sertoli cell tumor. 61
29606731 2018
30
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases. 61
29222199 2018
31
Benign Large-cell Calcifying Sertoli Tumor of the Testis in a 13-Year-Old Male Patient Treated With Partial Orchiectomy. 61
28551172 2017
32
Intratubular large cell hyalinizing Sertoli cell tumor of the testis presenting with prepubertal gynecomastia: a case report. 61
27488929 2017
33
Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation. 61
28871709 2017
34
An adolescent with large cell calcifying sertoli cell tumor of the testis and undiagnosed Carney Complex: A case report. 61
28276158 2017
35
Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms. 61
28445692 2017
36
A Hard Ball for a Tennis Player: A Rare Case of Large Calcifying Sertoli Cell Testicular Tumor. 61
28480167 2017
37
Response to Anastrozole Treatment in a Case with Peutz-Jeghers Syndrome and a Large Cell Calcifying Sertoli Cell Tumor. 61
27873740 2017
38
Surgical Therapy of 17α-hydroxylase Deficiency in 30 Patients. 61
27825414 2016
39
Prepubertal testicular tumors: a single-center experience of 44years. 61
26987710 2016
40
Sertoli cell tumor arising in a cryptorchid testis presenting as a content of inguinal hernial sac. 61
27510681 2016
41
Unusual Sertoli Cell Tumor Associated With Sex Cord Tumor With Annular Tubules in Peutz-Jeghers Syndrome: Report of a Case and Review of the Literature on Ovarian Tumors in Peutz-Jeghers Syndrome. 61
26621753 2016
42
Management of an invasive and metastatic Sertoli cell tumor with associated myelotoxicosis in a dog. 61
26933269 2016
43
A spontaneously occurring malignant ovarian Sertoli cell tumor in a young Sprague Dawley rat. 61
26989303 2016
44
LARGE CELL CALCIFYING SERTOLI CELL TUMOR OF THE TESTIS: A CASE REPORT. 61
28740051 2016
45
A CASE OF AN AROMATASE-PRODUCING SERTOLI CELL TUMOR PRESENTING WITH GYNECOMASTIA. 61
28442671 2016
46
Complete androgen insensitivity syndrome associated with bilateral sertoli cell adenomas and unilateral paratesticular leiomyoma: A case report. 61
29090880 2016
47
Expression of P450 Aromatase in Granulosa Cell Tumors and Sertoli-Stromal Cell Tumors of the Ovary: Which Cells Are Responsible for Estrogenesis? 61
26166720 2016
48
[Malignant Sertoli cell tumors of the testes]. 61
25821170 2015
49
What is your diagnosis? Cryptorchidism and Sertoli cell tumor. 61
25970213 2015
50
Testicular Nodules Suspected for Malignancy. Does the Pathologist Make the Difference for Organ-Sparing Surgery? . 61
26173351 2015
Sources

Variations for Sertoli Cell Tumor

About this section
Sources

Expression for Sertoli Cell Tumor

About this section
Search GEO for disease gene expression data for Sertoli Cell Tumor.
Sources

Pathways for Sertoli Cell Tumor

About this section

Pathways related to Sertoli Cell Tumor according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Cytoskeletal Signaling 4
12.11 VIM MUC1 KRT8 KRT7
2
Cytoskeleton remodeling Neurofilaments 22
Show member pathways
 11.58 VIM KRT8 KRT7
3
Nuclear Receptor transcription pathway 65
Show member pathways
 11.39 PGR NR5A1 AR
4
Embryonic and Induced Pluripotent Stem Cells and Lineage-specific Markers 64
11.38 WT1 VIM ALPP AFP
5
Primary Focal Segmental Glomerulosclerosis FSGS 1
11.2 WT1 VIM KRT8
6
Ovarian Infertility Genes 1
10.43 PGR NR5A1 INHA CYP19A1
Sources

GO Terms for Sertoli Cell Tumor

About this section

Biological processes related to Sertoli Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 SMAD protein signal transduction GO:0060395 9.5 VIM INHA AFP
2 positive regulation of male gonad development GO:2000020 9.46 WT1 NR5A1
3 prostate gland growth GO:0060736 9.43 CYP19A1 AR
4 steroid hormone mediated signaling pathway GO:0043401 9.43 PGR NR5A1 AR
5 sex determination GO:0007530 9.4 WT1 NR5A1
6 ovulation from ovarian follicle GO:0001542 9.37 PGR AFP
7 negative regulation of female gonad development GO:2000195 9.16 WT1 NR5A1
8 tertiary branching involved in mammary gland duct morphogenesis GO:0060748 8.96 PGR AR
9 male gonad development GO:0008584 8.92 WT1 NR5A1 INHA AR

Molecular functions related to Sertoli Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 zinc ion binding GO:0008270 9.63 WT1 PGR NR5A1 AR ALPP AFP
2 steroid hormone receptor activity GO:0003707 9.13 PGR NR5A1 AR
3 nuclear receptor activity GO:0004879 8.8 PGR NR5A1 AR
Sources

Sources for Sertoli Cell Tumor

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....